The results showed that the inhibitory effect of azelastine on CRC cell proliferation was significantly abrogated by Mdivi-1 (Figure S5F), suggesting that azelastine mainly exerts its bioactivity through inhibition of ARF1-mediated mitochondrial fission. This evidence concerns the gene ARF1 and colorectal carcinoma.